Covid Drug Paxlovid Now Less Effective Than In Early Trials

Paxlovid—Pfizer’s antiviral Covid-19 treatment—is 37% effective at preventing hospitalization or death in high-risk patients compared with no treatment, according to a study published Thursday in the JAMA Network Open, well below the 88% effectiveness rate Pfizer and regulators reported in…

#pfizer #delta #omicron #danyulin #nirmatrelvir #molnupiraviruse #omicroninfections